期刊文献+

EB病毒基因Z2A原核表达载体的构建及表达

Construction and expression of prokaryotic expression vector with EB virus gene Z2A
原文传递
导出
摘要 目的构建能分泌性表达EB病毒(Epstein—Barrvirus,EBV)融合基因Z2A的BCG重组质粒并导入BCG。方法分别以BCG和EBV融合基因eDNA为模板,通过PCR扩增得到139bp的BCG—Ag85B信号肽序列和2291bp的Z2A基因序列。将BCG-Ag85B信号肽序列与大肠杆菌一BCG穿梭表达载体pMV261重组,得到重组质粒pMVSo再将EBV融合基因序列Z2A亚克隆至pMVS中,得到重组质粒pMVZ2A,电转化导入BCG,采用十二烷基硫酸钠一聚丙烯酰胺凝胶电泳对表达产物进行分析。结果构建的重组质粒pMVZ2A经双酶切、PCR扩增及序列测定证实,克隆基因BCG-Ag85B信号肽和Z2A正确插入载体pMV261。重组质粒pMVZ2A电转化导入BCG后能在BCG中有效表达相应蛋白。结论构建的重组质粒pMVZ2A能在BCG中表达相应蛋白。这一结果为改造BCG及发展新型抗EBV和结核杆菌的双价疫苗奠定了基础。 Objective To construct a recombinant secretory plasmid of Bacillus Calmette-Guerin (BCG) Ag85B-fused EB virus genes, and then transform it into BCG. Methods BCG-Ag85B signal sequence and Z2A gene were amplified by PCR, respectively. BCG-Ag85B signal sequence was cloned in E. coli-BCG shuttle-vector pMV261 to obtain pMVS. Then a new recombinant plasmid pMVZ2A was constructed by inser- ting the Z2A gene into pMVS and transformed into BCG by electrotransformation. The expressed products were analyzed by SDS-PAGE. Results The cloned genes BCG-Ag85B and Z2A were correctly inserted into the vec- tor pMV261. The recombinant plasmid pMVZ2A was identified by double restriction enzyme digestion, PCR amplification and gene sequencing, respectively. The recombinant plasmid pMVZ2A effectively expressed Z2A in BCG after transformation. Conclusions pMVZ2A can effectively express Z2A in BCG. This study lays down the foundation for BCG reconstruction and development of new bivalent vaccine agaisnt EB virus and Mycobacterium tuberculosis.
作者 薛庆节 陈延
出处 《国际生物制品学杂志》 CAS 2010年第5期230-234,共5页 International Journal of Biologicals
基金 山东省卫生厅基金项目(2007HW035)
关键词 疱疹病毒4型 卡介苗 基因融合 遗传载体 Z2A Herpesvirus 4, human BCG vaccine Gene fusion Genetic vectors Z2A
  • 相关文献

参考文献7

  • 1Portis T,Longneeker R.Epstein-Barr virus(EBV) LMPZA alters normal transcriptional regulation following B-cell receptor activation[J].Virology,2004,318(2):524-533.
  • 2O'Donnell MA,Aldovini A,Duba RB,et al.Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes[J].Infect Immun,1994,62(2):2508-2514.
  • 3Sambrook KJ,Fritsch EF,Maniatis T.Molecular Cloning Laboratory Mannual[M].2nd ed.New York:Cold Sping Harbour Laboratory Press,1989.
  • 4朱伟,徐爱晶,罗兵.EB病毒LMP2A和EB病毒BZLF1融合基因反转录病毒表达载体的构建[J].中国组织工程研究与临床康复,2007,11(50):10109-10112. 被引量:3
  • 5Luo Y,Yamada H,Chen X,et al.Recombinant Mycobacterium bovisbacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity[J].Clin Exp Immunol,2004,137(1):24-34.
  • 6Yamada H,Kuroda E,Matsumoto S,et al.Prostaglandin E2 down-regulates viable Bacille Calmette-Guérin-induced macrophage cytotoxicity against murine bladder cancer cell MBT-2 in vitro[J].Clin Exp Immunol,2002,128(1):52-58.
  • 7Redchenko IV,Rickinson AB.Accessing Epstein-Barr virusspecific T-cell memory with peptide-loaded dendritic cells[J].J Virol,1999,73(1):3342-3421.

二级参考文献20

  • 1李忠,杨柳,陈光兴,林炎水,段小军.绿色荧光蛋白在组织工程关节软骨构建中的示踪作用[J].中国临床康复,2005,9(30):84-86. 被引量:4
  • 2萨姆布鲁克 J,拉塞尔 D W.分子克隆实验指南[M].3版.黄培堂,王嘉玺,朱厚础,等译.北京:科学出版社,2002:96—99;1232—1236.
  • 3Iwakid D,Takada K. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation. J Immunol 2004; 172:1561-1566.
  • 4Lee SP, Tiemey R J, Thomas WA, et al. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J Immunol 1997; 158(7):3325-3334.
  • 5Schaadt E, Baier B, Mautner J, et al. Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation. J Gen Virol 2005;86 (Pt 3):551-559.
  • 6Speck P, Kline KA, Cheresh P, et al. Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. J Gen Virol 1999;80 (Pt 8):2193.
  • 7Lu J, Lin WH, Chen SY, et al. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 2006,281 (13):8806-8814.
  • 8Portis T, Longecker R. Epstein-Barr virus ( EBV)LMP2A alters normal t ranscriptional regulation following B-cell receptor activation.Virology 2004; 318:524-533.
  • 9Kato K, Yokoyama A, Tohya Y, et al. Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine 35 that regulates its coactivator function. J Gen Virol 2003; 84 ( Pt 12) :3381-3392.
  • 10Igarashi M, Kawaguchi Y, Hirai K, et al. Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization. J Gen Virol 2003;84:319-327.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部